The short version of obesity research fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-05. Anything still debated is marked as such rather than presented as settled.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
In a study by Belicka et al., six sediment cores from two shelf-basin transects in the Chukchi and Beaufort Seas of the Arctic Ocean were examined in order to compare the sources and preservation of organic carbon between the two differing depositional regimes. This study found an unexpected correlation between dinosterol and α-amyrin, which is found in terrestrial plants, in shelf and slope sediments, in particular the Beaufort Shelf, suggesting that dinoflagellates contribute significantly to phytoplankton abundance in areas of seasonal open water. Dinosterol was only observed above the permanent ice pack, suggesting that dinoflagellates are restricted to open waters, which in the Arctic occur near the shallow shelves. Consequently, dinosterol may be a potential indicator of the history of open water conditions.
Co-Founder, Beacon Collaborative and Director, Rosa Fund. For services to Philanthropy, to Women and Girls, to the Arts and to the Economy. Charles Henry, Duke of Richmond and Gordon, DL. For services to Heritage, to Sport and to Charity. Kevin James David Ellis. Alliance Senior Partner, PwC UK and Middle East. For services to Economic Growth and Expanding Social Mobility. Nicholas Emery. Founding Partner and Chief Executive Officer, Brandtech Media. For services to the Media and Marketing Industries. Professor Paul Emery, OBE. Versus Arthritis Professor of Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Disease, University of Leeds. For services to Rheumatology. Professor Penelope Claire Endersby, FREng. Chief Executive Officer, Met Office. For services to Meteorology, to Defence Science and to Technology. Professor Kenneth John Falconer, FRSE. Regius Professor of Mathematics, University of St Andrews. For services to Mathematics. Angela Foulkes. Chief Executive and Principal, The Sheffield College. For services to Further Education. Yvonne Helen Fovargue, MP. Member of Parliament for Makerfield. For Political and Public Service. Timothy David Gardam. Journalist. For services to Journalism and to Education. Professor Danielle Amanda George, MBE. Professor of Radio Frequency Engineering, University of Manchester. For services to Public Engagement in Engineering. Dr. Phillip Anthony George. Lately Chair, Arts Council of Wales. For services to the Arts in Wales. Paul William Martin Golding. Chair, Pinewood Group.
The life science training pathway for clinical scientists follows a similar pathway to that undertaken by medically qualified specialist registrars in pathology. Clinical scientists are therefore the only discipline of non-medical healthcare professionals examined by a Medical Royal College. Clinical scientists who attain both part 1 examination certification and part 2 certification are awarded Fellowship of the Royal College of Pathologists (FRCPath) and are deemed to have the knowledge and expertise expected of a consultant level scientist. Consultant clinical scientist posts generally require candidates to have completed FRCPath qualification to be eligible. All clinical scientists regardless of seniority or specialisation may have other responsibilities including academic appointments, responsibilities as clinical lead for a pathology service, or may have wider hospital responsibilities such as directorship of Infection Prevention and Control, or responsibility for the hospital's Research and Development strategy. Junior clinical scientists may become involved in academic research, working towards a Ph.D. or DClinSci.
Carbodiimides such as dicyclohexylcarbodiimide (DCC) and diisopropylcarbodiimide (DIC) are frequently used for amide bond formation. The reaction proceeds via the formation of a highly reactive O-acylisourea. This reactive intermediate is attacked by the peptide N-terminal amine, forming a peptide bond. Formation of the O-acylisourea proceeds fastest in non-polar solvents such as dichloromethane. DIC is particularly useful for SPPS since as a liquid it is easily dispensed, and the urea byproduct is easily washed away. Conversely, the related carbodiimide 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) is often used for solution-phase peptide couplings as its urea byproduct can be removed by washing during aqueous work-up.
=== Trauma === The bony area that makes up the human eye socket provides exceptional protection to the sclera. However, if the sclera is ruptured by a blunt force or is penetrated by a sharp object, the recovery of full former vision is usually rare. If pressure is applied slowly, the eye is actually very elastic. However, most ruptures involve objects moving at some velocity. The cushion of orbital fat protects the sclera from head-on blunt forces, but damage from oblique forces striking the eye from the side is not prevented by this cushion. Hemorrhaging and a dramatic drop in intraocular pressure are common, along with a reduction in visual perception to only broad hand movements and the presence or absence of light. However, a low-velocity injury which does not puncture and penetrate the sclera requires only superficial treatment and the removal of the object. Sufficiently small objects which become embedded and which are subsequently left untreated may eventually become surrounded by a benign cyst, causing no other damage or discomfort.
Sources: en.wikipedia.org
γ-glutamyl cysteine + ADP + Pi GSH, and by extension GCL, is critical to cell survival. Nearly every eukaryotic cell, from plants to yeast to humans, expresses a form of the GCL protein for the purpose of synthesizing GSH. To further highlight the critical nature of this enzyme, genetic knockout of GCL results in embryonic lethality. Furthermore, dysregulation of GCL enzymatic function and activity is known to be involved in the vast majority of human diseases, such as diabetes, Parkinson's disease, Alzheimer's disease, COPD, HIV/AIDS, and cancer. This typically involves impaired function leading to decreased GSH biosynthesis, reduced cellular antioxidant capacity, and the induction of oxidative stress. However, in cancer, GCL expression and activity is enhanced, which serves to both support the high level of cell proliferation and confer resistance to many chemotherapeutic agents.
Interferon beta-1a administered subcutaneously or intravenously was investigated since March 2020 as a potential treatment in patients hospitalized with COVID-19 in a multinational Solidarity trial (initially in combination with lopinavir) but it did not reduce in-hospital mortality compared to local standard of care. SNG001, an inhalation formulation of interferon beta-1a, is being developed as a treatment for COVID-19 by Synairgen. A pilot trial in hospitalized patients showed higher odds of clinical improvement with SNG001 compared to placebo and in January 2021 a phase 3 trial in this population started.
Pharmacies within hospitals differ considerably from community pharmacies. Some pharmacists in hospital pharmacies may have more complex clinical medication management issues, and pharmacists in community pharmacies often have more complex business and customer relations issues. Because of the complexity of medications including specific indications, effectiveness of treatment regimens, safety of medications (i.e., drug interactions) and patient compliance issues (in the hospital and at home), many pharmacists practicing in hospitals gain more education and training after pharmacy school through a pharmacy practice residency, sometimes followed by another residency in a specific area. Those pharmacists are often referred to as clinical pharmacists and they often specialize in various disciplines of pharmacy. For example, there are pharmacists who specialize in hematology/oncology, HIV/AIDS, infectious disease, critical care, emergency medicine, toxicology, nuclear pharmacy, pain management, psychiatry, anti-coagulation clinics, herbal medicine, neurology/epilepsy management, pediatrics, neonatal pharmacists and more. Hospital pharmacies can often be found within the premises of the hospital. Hospital pharmacies usually stock a larger range of medications, including more specialized medications, than would be feasible in the community setting. Most hospital medications are unit-dose, or a single dose of medicine.
Platelets are activated by collagen receptor glycoprotein IV (GPVI). Proinflammatory platelet microvesicles trigger constant cytokine secretion from neighboring fibroblast-like synoviocytes, most prominently Il-6 and Il-8. Inflammatory damage to the surrounding extracellular matrix continuously reveals more collagen, binding receptors on platelets and maintaining microvesicle production.
Sources: en.wikipedia.org
Data from the Moneyfacts Group suggests the average rate on a two-year fixed-term mortgage has fallen below 6% for the first time since June 2023. The Court of Session in Edinburgh rules that the UK government acted lawfully by blocking the Gender Recognition Reform (Scotland) Bill from becoming law, and rejects the Scottish Government's appeal against the decision. At the Old Bailey, Paul Bryan is sentenced to life imprisonment with a minimum of 24 years for the 1984 murder of Roman Szalajko at the victim's south London home. Bryan assumed the identity of a dead man with the same name, but was traced through a fingerprint match in 2022. After footballer Joey Barton suggests that women "should not be talking with any kind of authority" about men's football, Chelsea manager Emma Hayes says women are "routinely used to dealing with systemic misogyny and bullying" in football. Wham!'s Last Christmas tops the singles chart for the fourth time with Mariah Carey's All I Want For Christmas Is You taking the second spot. A week after the death of Shane MacGowan from The Pogues, Fairytale of New York rises to number four. 9 December Yellow weather warnings are in place for much of the UK as two successive storms, Elin and Fergus, reach the UK from the Atlantic, bringing high winds and heavy rain. The royal family reveal their Christmas card images with King Charles III choosing a photograph from his coronation earlier this year for his second Christmas as monarch.
=== 1880s === 1880: Self-taught German chemist Agnes Pockels began investigating surface tension, becoming a pioneering figure in the field of surface science. The measurement equipment she developed provided the basic foundation for modern quantitative analyses of surface films. 1880: Norwegian zoologist and malacologist Birgitte Esmark's publication on mollusks becomes the first time in Norway that a woman had a scientific work published. 1881: Italian scientists Evangelina Bottero and Carolina Magistrelli became the first women to achieve doctoral degrees in science in unified Italy. 1883: American ethnologist Erminnie A. Smith, the first female field ethnographer, published her collection of Iroquois legends Myths of the Iroquois. 1884: English zoologist Alice Johnson's paper on newt embryos became the first paper authored by a woman to appear in the Proceedings of the Royal Society. 1885: British naturalist Marian Farquharson became the first female Fellow of the Royal Microscopical Society. 1886: American botanist Emily Lovira Gregory became the first female member of the American Society of Naturalists. 1887: Rachel Lloyd became the first American woman to receive a PhD in chemistry, completing her research at the Swiss University of Zurich. 1888: Russian scientist Sofia Kovalevskaya discovered the Kovalevskaya top, one of a brief list of known rigid body motion examples that are tractable by manipulating equations by hand. 1888: Scottish astronomer Williamina Fleming discovered the Horsehead Nebula on a telescope-photogrammetry plate.
I hit him over the head with my 'rod of iron' (a section of the rear axle of an automobile)." Karriem recalled his children sobbed and begged him, "please, Daddy, don't do it, don't do it!" On November 22, press coverage included a picture of the "Voodoo house" where the slaying had occurred. It was revealed that he had taken on the name "Karriem", referring to "Harris" as his 'slave name'. His son has likewise been renamed Hasabas. Hasabas, age 12, and daughter Ruby, 9, had been forced to witness the ritual. Press reported: "With an insane light in his eyes, he admitted that he had planned to seek out and kill Judges Edward J. Jeffries and Arthur E Gordon for the purpose of propitiating jungle gods." Karriem also reported wanting to kill a 21 year old social worker who had cut him from welfare rolls. Karriem was compared to the Ahfed Abdullah, formerly James Moaning, described as psychopathic, who had gained entrance to the Mayor's home in the delusional belief that the Mayor was responsible for the government of Haiti. On November 23, press discussed police access to a temple on Hasting Street using a secret password, their raid on the temple, and their arrest of leader Ugan Ali, described as 'God of the Asiatics', after he admitted to having taught Karriem. Police initiated a manhunt for Fard and another leader, Ugan Ali, who were arrested and questioned. Karriem was deemed insane and committed to a mental hospital. "The society cannot be blamed for anything he did", Ali was quoted as saying in the Detroit News.
=== Aging === Targeting ferroptosis has emerged as a strategy for mitigating age-related tissue decline. Chronic low-grade systemic inflammation (inflammaging), a hallmark of aging, has been identified as a primary trigger for ferroptotic death in muscle stem cell (MuSC) populations. In mice, long-term administration of the anti-inflammatory compound bindarit, initiated at midlife, suppresses age-associated inflammation and prevents the epigenetic erosion of the Kmt5a–H4K20me1 axis in MuSCs. This preserves the expression of the antioxidant enzyme GPX4, shielding the MuSC pool from iron-dependent lipid peroxidation and maintaining regenerative capacity during aging. More broadly, inhibition of ferroptosis — through radical-trapping antioxidants such as ferrostatin-1 and liproxstatin-1, or through iron chelation — extends lifespan and healthspan in model organisms such as Caenorhabditis elegans. In the context of osteoarthritis, senescent macrophages in skeletal muscle have been shown to promote ferroptosis in myofibers through iron overload and disruption of coenzyme Q10 biosynthesis, contributing to peri-articular muscle atrophy; treatment with CoQ10 attenuates this process.
== External links == "Tiratricol ( Code - C66605 )". EVS Explore. "Tiratricol Sodium ( Code - C218928 )". EVS Explore. Clinical trial number NCT05579327 for "Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency) (ReTRIACt)" at ClinicalTrials.gov Clinical trial number NCT02060474 for "Thyroid Hormone Analog Therapy in MCT8 Deficiency: Triac Trial Patients" at ClinicalTrials.gov
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.